Skip to main content
Advertisement
  • Loading metrics

Correction: CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria

  • Dennise Palacios Araya,
  • Kelli L. Palmer,
  • Breck A. Duerkop

There is an error in the sixth sentence of the first paragraph of the Introduction which should not include reference to Intellia Therapeutics. The correct sentence is: These promising targeted therapies are the focus of synthetic biology companies such as Locus Biosciences and Eligo Bioscience, to name a few.

Reference

  1. 1. Palacios Araya D, Palmer KL, Duerkop BA (2021) CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria. PLoS Pathog 17(7): e1009672. https://doi.org/10.1371/journal.ppat.1009672 pmid:34237097